<DOC>
	<DOCNO>NCT02095015</DOCNO>
	<brief_summary>Mucopolysaccharidosis ( MPS ) type II ( MPS II ; Hunter syndrome ) rare , X-linked disease cause deficiency lysosomal enzyme iduronate-2-sulfatase ( I2S ) occur almost exclusively boys , incidence approximately 1.3 per 100,000 live male births.1 Early identification MPS II challenge initial feature , chronic runny nose , otitis medium , hernia , commonly see general population . As result , even though sign symptom MPS II typically appear early childhood , diagnosis may lag behind several year . The primary objective international multi-center study evaluate positive screening rate MPS II subject screen high-risk male pediatric population schedule 1 specific ENT surgical procedure ( adenoidectomy and/or tonsillectomy and/or tympanostomy ) previously repair present evidence inguinal and/or umbilical hernia .</brief_summary>
	<brief_title>Mucopolysaccharidosis ( MPS ) I , II , VI Screening High-Risk Population With Previous Surgical Repair Presence Inguinal and/or Umbilical Hernia Combination With Pediatric ENT Surgery ( The HATT Project )</brief_title>
	<detailed_description>With evidence-based information MPS registries regard type surgical intervention prevalent MPS , screen study expect provide understanding role pediatric ENT surgeon play identify young child MPS .</detailed_description>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Hernia , Umbilical</mesh_term>
	<mesh_term>Mucopolysaccharidosis I</mesh_term>
	<mesh_term>Mucopolysaccharidosis II</mesh_term>
	<mesh_term>Mucopolysaccharidosis VI</mesh_term>
	<criteria>Each subject must meet follow criterion enrol study : 1 . The subject male . 2 . The subject &lt; 7 year age . 3 . The subject schedule ENT surgery follow , alone combination : adenoidectomy , tonsillectomy , tympanostomy . 4 . The subject record previous surgical repair presence inguinal and/or umbilical hernia . 5 . The subject 's parent ( ) subject 's legally authorize representative ( ) provide write informed consent approve Institutional Review Board/Independent Ethics Committee ( IRB/IEC ) . Subjects meet follow criterion exclude study : 1 . The subject current confirm diagnosis MPS disorder . 2 . The subject born prematurely ( define born 37 week gestation ) . 3 . The subject receive blood transfusion within past 6 week . 4 . The subject receive bone marrow transplant .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>MPS</keyword>
	<keyword>Mucopolysaccharidosis</keyword>
	<keyword>MPS I</keyword>
	<keyword>Mucopolysaccharidosis I</keyword>
	<keyword>Hurler , Hurler-Scheie , Scheie syndrome</keyword>
	<keyword>MPS II</keyword>
	<keyword>Mucopolysaccharidosis II</keyword>
	<keyword>Hunter syndrome</keyword>
	<keyword>MPS VI</keyword>
	<keyword>Mucopolysaccharidosis VI</keyword>
	<keyword>Maroteaux-Lamy syndrome</keyword>
	<keyword>iduronate-2-sulfatase</keyword>
	<keyword>ENT</keyword>
	<keyword>ear , nose throat</keyword>
</DOC>